IGC Pharma, Inc. Quarterly Other Long-term Investments in USD from Q1 2011 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of long-term investments classified as other.
Summary
IGC Pharma, Inc. quarterly Other Long-term Investments history and growth rate from Q1 2011 to Q1 2022.
  • IGC Pharma, Inc. Other Long-term Investments for the quarter ending March 31, 2022 was $0.000, a 100% decline year-over-year.
Other Long-term Investments, Quarterly (USD)
Other Long-term Investments, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2022 $0 -$12K -100% Mar 31, 2022 10-K 2022-06-23
Q4 2021 $11K -$250K -95.8% Dec 31, 2021 10-Q 2022-02-10
Q3 2021 $11K -$250K -95.8% Sep 30, 2021 10-Q 2021-10-29
Q2 2021 $11K -$249K -95.8% Jun 30, 2021 10-Q 2021-08-11
Q1 2021 $12K +$1K +9.09% Mar 31, 2021 10-K 2022-06-23
Q4 2020 $261K -$533K -67.1% Dec 31, 2020 10-Q 2021-02-16
Q3 2020 $261K -$533K -67.1% Sep 30, 2020 10-Q 2020-11-20
Q2 2020 $260K -$534K -67.3% Jun 30, 2020 10-Q 2020-08-19
Q1 2020 $11K -$783K -98.6% Mar 31, 2020 10-K 2021-06-14
Q4 2019 $794K $0 0% Dec 31, 2019 10-Q 2020-02-10
Q3 2019 $794K $0 0% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $794K -$1.28K -0.16% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $794K -$5K -0.63% Mar 31, 2019 10-K 2020-07-13
Q4 2018 $794K -$5.22M -86.8% Dec 31, 2018 10-Q 2019-02-12
Q3 2018 $794K -$4.45M -84.8% Sep 30, 2018 10-Q 2018-10-16
Q2 2018 $795K -$4.44M -84.8% Jun 30, 2018 10-Q 2018-08-03
Q1 2018 $799K -$5.21M -86.7% Mar 31, 2018 10-K 2019-06-14
Q4 2017 $6.02M +$786K +15% Dec 31, 2017 10-Q 2018-02-20
Q3 2017 $5.24M +$9.9K +0.19% Sep 30, 2017 10-Q 2017-11-17
Q2 2017 $5.24M +$9.87K +0.19% Jun 30, 2017 10-Q 2017-08-18
Q1 2017 $6.01M +$836K +16.1% Mar 31, 2017 10-K 2018-06-21
Q4 2016 $5.23M +$5.2M +19199% Dec 31, 2016 10-Q 2017-02-21
Q3 2016 $5.23M +$5.2M +17940% Sep 30, 2016 10-Q 2016-11-21
Q2 2016 $5.23M +$5.2M +17413% Jun 30, 2016 10-Q 2016-08-16
Q1 2016 $5.18M +$5.14M +16881% Mar 31, 2016 10-K 2017-07-14
Q4 2015 $27.1K -$891K -97% Dec 31, 2015 10-Q 2016-02-16
Q3 2015 $29K -$1.68K -5.47% Sep 30, 2015 10-Q 2015-11-13
Q2 2015 $29.9K -$1.76K -5.55% Jun 30, 2015 10-Q 2015-08-14
Q1 2015 $30.5K -$1.17K -3.71% Mar 31, 2015 10-K 2016-07-14
Q4 2014 $918K +$870K +1795% Dec 31, 2014 10-Q 2015-02-12
Q3 2014 $30.7K -$17.3K -36% Sep 30, 2014 10-Q 2014-11-13
Q2 2014 $31.6K -$18.8K -37.3% Jun 30, 2014 10-Q 2014-08-14
Q1 2014 $31.7K -$51.8K -62.1% Mar 31, 2014 10-K 2015-07-14
Q4 2013 $48.5K -$199K -80.4% Dec 31, 2013 10-Q 2014-02-14
Q3 2013 $47.9K -$264K -84.6% Sep 30, 2013 10-Q 2013-11-08
Q2 2013 $50.4K -$302K -85.7% Jun 30, 2013 10-Q 2013-08-16
Q1 2013 $83.5K -$554K -86.9% Mar 31, 2013 10-K 2014-07-15
Q4 2012 $247K -$519K -67.7% Dec 31, 2012 10-Q 2013-02-13
Q3 2012 $312K -$547K -63.7% Sep 30, 2012 10-Q 2012-11-14
Q2 2012 $352K -$561K -61.4% Jun 30, 2012 10-Q/A 2012-08-21
Q1 2012 $638K -$240K -27.4% Mar 31, 2012 10-K/A 2014-07-15
Q4 2011 $766K Dec 31, 2011 10-Q 2012-02-16
Q3 2011 $859K Sep 30, 2011 10-Q 2011-11-18
Q2 2011 $913K Jun 30, 2011 10-Q 2011-08-18
Q1 2011 $878K Mar 31, 2011 10-K 2012-07-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.